Assessment of Myocardial 18 F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients
Radiology · 2023
DOI: 10.1148/radiol.230743 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiology, 2023. Verfasst von Takehiro Nakahara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Myocarditis, COVID-19. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: British Heart Foundation.
Abstract (Originalsprache)
Background
Patients who developed myocarditis following SARS-CoV-2 vaccination show abnormalities on cardiac MRI. However, whether myocardial changes occur in asymptomatic individuals following vaccination is not well established.
Purpose
To assess myocardial 18Fluorine-fluorodeoxyglucose (18F-FDG) uptake on PET/CT in asymptomatic SARS-CoV-2 vaccinated patients compared to nonvaccinated patients. Materials and Methods This retrospective study included patients who underwent 18F-FDG PET/CT for indications unrelated to myocarditis during the period before (11/1/2020 - 2/16/2021) and after (2/17/20121 - 3/31/2022) SARS-CoV-2 vaccines were available. Myocardial and axillary FDG uptake were quantitatively assessed using maximum standardized uptake value (SUVmax). SUVmax values in all patients and in patients stratified by sex (male/female), age ( 60 years), and time interval between vaccination and PET/CT were compared using Mann-Whitney U test or Kruskal-Wallis test with post ad -hoc Dwass, Steel, Critchlow-Fligner multiple comparison analysis.
Results
The study included 303 nonvaccinated patients (mean age, 52.9 years ± 14.9 [SD]; 157 females) and 700 vaccinated patients (mean age, 56.8 years ± 13.7 [SD]; 344 females). Vaccinated patients had overall higher myocardial FDG uptake compared to nonvaccinated patients (median SUVmax, 4.8 [IQR: 3.0-8.5] vs median SUVmax, 3.3 [IQR: 2.5-6.2]; P < .0001). Myocardial SUVmax was higher in vaccinated patients regardless of sex (median range, 4.7-4.9 [IQR: 2.9-8.6]) or patient age (median range, 4.7-5.6 [IQR: 2.9-8.6]) compared to corresponding nonvaccinated groups (sex median range, 3.2-3.9 [IQR: 2.4-7.2]; age median range, 3.3-3.3 [IQR: 2.3-6.1]; P range,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Keio University School of Medicine, Tokyo, Japan.
- Advanced Clinical Research Center, Fukushima Medical University, Fukushima, Japan.
- Icahn School of Medicine at Mount Sinai, New York.
- University of Oxford Radcliffe Hospital, Oxford, UK.
- Medicine & Cardiology, McGovern Medical School, Houston, Texas.
ORCID-Profile: Takehiro Nakahara, Yu Iwabuchi, Raita Miyazawa, Kai Tonda, H William Strauss, Charalambos Antoniades, Jagat Narula
Förderung
- British Heart Foundation
Zitieren
APA
Nakahara, T., Iwabuchi, Y., Miyazawa, R., Tonda, K., Shiga, T., Strauss, H. W., Antoniades, C., Narula, J., & Jinzaki, M. (2023). Assessment of Myocardial 18 F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients. Radiology. https://doi.org/10.1148/radiol.230743
Vancouver
Nakahara T, Iwabuchi Y, Miyazawa R, Tonda K, Shiga T, Strauss HW, et al. Assessment of Myocardial 18 F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients. Radiology. 2023. doi:10.1148/radiol.230743
BibTeX
@article{Nakahara2023,
author = {Nakahara, Takehiro and Iwabuchi, Yu and Miyazawa, Raita and Tonda, Kai and Shiga, Tohru and Strauss, H William and Antoniades, Charalambos and Narula, Jagat and Jinzaki, Masahiro},
title = {Assessment of Myocardial 18 F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients},
journal = {Radiology},
year = {2023},
doi = {10.1148/radiol.230743}
}
EUVIMED